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Abstract
Background: Predicting and monitoring recruitment in large, complex trials is essential to ensure appropriate
resource management and budgeting. In a novel partnership between clinical trial investigators of the South
African Medical Research Council and industrial engineers from the Stellenbosch University Health Systems
Engineering and Innovation Hub, we developed a trial recruitment tool (TRT). The objective of the tool is to serve
as a computerised decisions-support system to aid the planning and management phases of the trial recruitment
process.
Method: The specific requirements of the TRT were determined in several workshops between the partners. A
Poisson process simulation model was formulated and incorporated in the TRT to predict the recruitment duration.
The assumptions underlying the model were made in consultation with the trial team at the start of the project
and were deemed reasonable. Real-world data extracted from a current cluster trial, Project MIND, based in 24 sites
in South Africa was used to verify the simulation model and to develop the monitoring component of the TRT.
Results: The TRT comprises a planning and monitoring component. The planning component generates different
trial scenarios for predicted trial recruitment duration based on user inputs, e.g. number of sites, initiation delays.
The monitoring component uses and analyses the data retrieved from the trial management information system to
generate different levels of information, displayed visually on an interactive, user-friendly dashboard. Users can
analyse the results at trial or site level, changing input parameters to see the resultant effect on the duration of trial
recruitment.
Conclusion: This TRT is an easy-to-use tool that assists in the management of the trial recruitment process. The TRT
has potential to expedite improved management of clinical trials by providing the appropriate information needed
for the planning and monitoring of the trial recruitment phase. This TRT extends prior tools describing historic
recruitment only to using historic data to predict future recruitment. The broader project demonstrates the value of
collaboration between clinicians and engineers to optimise their respective skillsets.
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Background
Trials, specifically multi-centre trials, require a large in-
vestment of money, human resources and time. Effective
planning and trial management are key to conducting
trials within budget and timelines. Information about
trial duration is essential for management decision-
making during the planning and conduct stages of a
trial. Principal investigators (PI) need to decide whether
a trial is feasible based on the time it would take to
complete, funding availability and the authorisations re-
quired from governing bodies and agreement terms with
clinics, staff, community partners and patients [1–6].
The duration of a trial recruitment phase is typically
the most difficult to predict prior to the trial, and to
manage during the trial, due to the uncertainty and vari-
ability of factors that influence recruitment [4, 7–9]. Fac-
tors that may impact on trial recruitment include
convenience of trial site and duration to participants, in-
centives and compensation, study staffing and nature of
the intervention. Inaccurate estimations of the recruit-
ment duration often result in prolonged periods required
to reach the specified sample size. This directly results
in increased costs, which often leads to an exceeded
budget. Prolonged recruitment may also result in in-
creasing reluctance on the part of stakeholders—clinics,
staff or patients—to participate in the trial [4, 10–12].
Should PIs decide to decrease the sample size due to
poor recruitment or to terminate the trial early, study
power may be threatened if the target sample size is not
reached. In extreme cases, the trial may be at risk of a
type II error where results are found to be incorrectly
statistically non-significant [10–12]. Abandoned studies
are a waste of effort and a financial detriment to a re-
search programme and funding agencies, resulting in
complete loss of invested capital [11, 13].
There has been increased research interest in the mod-
elling and prediction of trial recruitment duration (TRD)
[7, 14–18]. These techniques have the potential to en-
able informed decision-making during the pre-trial plan-
ning and recruitment phases of the trial and ultimately
contribute to greater efficiency in trial management [9].
Limited work has been published on how the outputs of
the TRD prediction techniques and other information
collected during the trial may be utilised to assist or im-
prove decision-making to address typical difficulties in
trial management [3]. Although software packages are
available that can assist in this decision-making, they
tend to be expensive and may be prohibitively so for re-
searchers in low- and middle-income countries. Spend-
ing scarce resources on software purchases during the
pre-trial planning phase, and to determine trial feasibil-
ity, is undesirable when budgets are limited. In the ab-
sence of simple to use, open-source recruitment
planning software, many investigators from LMICs rely
on experience from prior studies to estimate recruitment
rates, but this becomes more complex and less accurate
when studies involve multiple sites.
In 2016, trial investigators from the South African Med-
ical Research Council (SAMRC) approached the Health
System Engineering and Innovation Hub (HSE&IH) from
the Department of Industrial Engineering at Stellenbosch
University to partner in developing a tool to aid trial re-
cruitment planning and management. The collaboration
aimed to utilise the unique expertise from both the clinical
research and industrial engineering disciplines to develop
a predictive tool which would require minimal additional
knowledge to that typically possessed by a clinical trial in-
vestigator and would utilise freely available resources to
develop, implement and apply.
The purpose of this paper is (1) to describe the design
and development of a trial recruitment tool (TRT) to
support recruitment planning and monitoring in both
single and multi-site clinical trials and (2) to demon-
strate the applicability and usability of the tool in a real-
world active cluster randomised controlled trial.
Method
Project MIND
Project MIND is a three-arm cluster randomised con-
trolled trial (RCT) comparing the effectiveness of two
different resourcing approaches to integrating mental
health counselling into chronic disease care relative to
treatment as usual (TAU) for reducing hazardous alco-
hol use and depression and improving HIV and diabetes
treatment outcomes [19]. In this trial, patients were re-
cruited from 24 primary care clinics in the Western
Cape province of South Africa. These facilities were
stratified by urban-rural status before being randomly
assigned to either treatment-as-usual or one of two
intervention conditions. At each site, study assessors
screened patients presenting for routine HIV or diabetes
treatment for study eligibility. Eligibility criteria included
(i) being at least 18 years old, (ii) taking antiretroviral
therapy (ART) for HIV or medication for diabetes, (iii)
screening positive for hazardous drinking or depression
and (iv) providing consent to all study procedures. Pa-
tients receiving other mental health treatment or partici-
pating in another study were excluded. If eligible
patients were interested in study participation, an ap-
pointment was made for the enrolment visit. These pro-
cedures were followed until 25 unique participants with
HIV and 25 unique participants with diabetes were re-
cruited from each site.
After obtaining consent, the participant completed a
computer-assisted personal interview about their HIV or
diabetes treatment, common mental disorders and con-
tributing psychosocial factors, perceived health status
and health service use. Participants also provided blood
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samples for HIV viral load and HbA1c testing to assess
the extent to which their chronic disease was well-
controlled. Participants recruited from an intervention
site then received the first of three counselling sessions.
Participants were given 6 weeks to complete the three-
session intervention and an additional 2 weeks to
complete the optional fourth session. All participants
were tracked for 6 and 12-month post-enrolment assess-
ments in which the baseline interview was read
ministered.
Ethics approval for this trial was obtained from the
South African Medical Research Council (EC 004–2/
2015), the University of Cape Town (089/2015) and Ox-
ford University (OxTREC 2–17). The Western Cape De-
partment of Health also approved this study (WC2016_
RP6_9). The trial is registered with the Pan African Clin-
ical Trials Registry (trial registration number: PACT
R201610001825403).
Development of trial recruitment tool
The specific requirements of the tool were determined
in several workshops between the clinical investigators
from Project MIND and the engineering researchers
from the HSE&IH. During the workshops, specific trial
recruitment problems were identified, and the type of in-
formation required to potentially mitigate these prob-
lems was determined. The findings are summarised in
Table 1.
Since data collection is a core component of any trial,
we determined that the information required for recruit-
ment management should be derivable from the data
captured by trial field workers during recruitment. A
major information requirement for both the recruitment
planning and monitoring phases is expected trial recruit-
ment duration.
A large number of studies have proposed and applied
various methods and models for predicting TRD, includ-
ing both analytical and simulation approaches [9, 14–16,
20–23]. Analytical approaches, such as the Poisson-
gamma model applied by Anisimov [21], develop analyt-
ical expressions to predict the TRD based on statistical
models. Simulation approaches, such as the method pro-
posed by Lan et al. [14], provide a dynamic means of
predicting TRD which allows more complex, time-
dependent factors to be considered.
In this research, a pragmatic simulation approach is se-
lected to predict the TRD such as to demonstrate how dy-
namic approaches which incorporate existing trial data
may be applied in an interactive tool, allowing application
of the approach without requiring statistical expertise.
The requirements for the model were to (1) reflect the
real-world recruitment process, (2) incorporate existing
trial data and (3) be implementable within the tool.
The Poisson distribution was chosen to drive the
simulation model based on the nature of the recruitment
process and its widespread application to prediction [14,
15, 20, 24–26]. The three assumptions required to use
the Poisson distribution for the trial recruitment process
are verified in Table 2.
To ensure that the Poisson distribution was represen-
tative of the real-world process, trial screening and re-
cruitment data from Project MIND was analysed using
multiple chi-squared goodness of fit tests. With the as-
sistance of trial stakeholders, we selected five trial sites
that provided the most accurate representation of the
typical recruitment rate, i.e. sites that did not experience
any external problems during the recruitment period.
From the chi-square tests performed on the real-world
data (see Supplementary Material), there was not enough
evidence available to conclude that the data poorly fits
the Poisson distribution (p = 0.14; 0.67; 0.62; 0.18; 0.60).
The Poisson distribution was, therefore, used to formu-
late the simulation technique. The following technique
was adapted from Carter [24] to meet the identified re-
quirements of the problem and to increase the efficiency
in running the simulation:
Table 1 Information requirements to mitigate typical trial recruitment problems
Phase Problem Desirable information requirements for decision-
making
Planning Overestimation of the number of potential participants who meet the
criteria and would be willing to participate in trial
• No existing information available
Underestimation of the time it takes recruit the required sample size • Expected trial and site recruitment duration
• Information on how expected trial duration changes
when trial parameters are changedNot taking variability into account when predicting recruitment duration
Overestimation of the recruitment rate • No existing information available
Recruitment Latest recruitment information not available to decision makers • Current recruitment progress for the trial
• Expected end-date of trial recruitment
• Current recruitment progress for the site
• Expected remaining recruitment duration
• Information on potential problematic sites
• Information on how expected site duration changes
when site parameters are changed
Recruitment information is not presented in a manner that allows necessary
decisions to be made
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1. Sample values from Poisson distribution
2. Each sample value represents recruitments at
successive time periods
3. Calculate cumulative values and determine which
period goal is met
4. Replicate the process to form samples of expected
duration
5. Calculate the mean of each sample
6. Calculate the duration confidence interval based on
the sample information
A more thorough explanation to the mathematics behind
the technique can be found in the Supplementary Material.
Cluster trials typically consist of multiple sites with the
recruitment at each site being independent of the others
and the rate at which recruitment occurs differing across
sites. Sites have different recruitment goals and may start
recruitment at different periods. These factors make it
impossible to aggregate the information of different sites
to predict the overall TRD. Sites are, therefore, simu-
lated individually, based on the site’s recruitment goal
and recruitment rate.
The recruitment goal of the site is specified during the
trial design phase but may be changed during the re-
cruitment phase, due to various operational factors. For
the purposed of the tool, the recruitment rate for each
site may be specified a priori or calculated based on the
available trial recruitment data. The simulation model is
executed at each of the sites, resulting in a predicted
TRD for each site. The expected TRD for the trial can
then be determined by identifying the latest end date of
all the different sites. Figure 1 illustrates this method by
depicting the TRD of six different sites.
Due to the resource-constrained environment in which
the TRT was to be developed, implemented and used,
development on free software was essential. R with the
Shiny package is chosen for the development of the
TRT. Shiny is an R package that allows interactive appli-
cations and user-friendly deployable front-ends to be
built using R code, a programming language and free
software environment [30].
Results
We developed the TRT consisting of two major compo-
nents, which are discussed in the following sections. The
source code of the TRT, as well as hypothetical sample
data which may be used to explore the tool functionality,
is available on GitHub and may be accessed at https://
github.com/spiesruan/TrialRecruitmentTool.
Planning component of the TRT
The trial recruitment planning component assists
decision-making during the planning phase of a clinical
trial and comprises single site and multisite planning.
Table 2 Verification of the Poisson assumptions in the trial recruitment context
Assumption Trial recruitment context Assumption
holds
Events taking place during one interval do not
affect the next
Each recruitment is independent of the next Yes
Events take place one at a time Patients are recruited individually, and recruitment data is recorded one at a time Yes
The average rate of events remains constant The assumption has been challenged by Williford et al. [27], but numerous other
sources support the assumption [26, 28, 29]
Yes
Fig. 1 Determining trial recruitment duration by comparing end dates of different sites
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Single site planning
The single site planning component provides a rough es-
timation of how long a trial or site is expected to take to
recruit a specified sample size and can be deployed be-
fore exact site details are known. Specific known param-
eters, as shown in Fig. 2, are used by the simulation
model to calculate and display the expected TRD. The
initial values, which are displayed in the input areas of
the TRT, are typical values that would be used for plan-
ning based on previous data.
Multisite planning
The multisite planning component allows the expected
TRD to be predicted with greater accuracy by incorporat-
ing several different sites, each with their own parameters.
It allows consideration of different scenarios and facilitates
planning decisions based on the information presented.
Once the number of sites is specified, a table based on the
number of sites is generated and the parameters for each
site can be inputted. As for single site planning, expected
recruitment rate and goals for each site are required, with
the option to input initiation delays if the site will only
start recruiting after a specified period.
The input parameters are used to predict the recruit-
ment duration for each site, and the overall TRD dis-
played on the dashboard is taken to be the duration
from the start of recruitment until the last patient is re-
cruited. This may be derived by considering the pre-
dicted completion period of the site that is expected to
complete recruitment last, termed the determinative site.
The results are visualised as shown in Fig. 3.
Monitoring component of the TRT
The trial recruitment monitoring component uses and
analyses the data retrieved from the trial management
information system and displays it graphically. Real-
world trial data is entered as a comma-separated value
file or Excel spreadsheet into the TRT. The data is
processed in the background and the three displays,
discussed in the following sections, are generated. We
Fig. 2 Single site planning user input
Spies et al. Trials          (2021) 22:189 Page 5 of 9
demonstrate this application to data from the Project
MIND trial.
Trial overview component
The trial overview component provides the highest-level
summary of the trial progress by displaying a single view
of all the current recruitment data. The total number of
recruitments and a graph of the cumulative number of
recruitments over the entire period are shown. Simula-
tions for each site are performed in the background,
based on the provided data and baseline information.
The determinant site, with the longest expected
remaining duration, is displayed.
Site overview component
The site overview component uses the baseline informa-
tion to plot the different sites on an interactive map.
When a site is selected, the site’s recruitment informa-
tion is displayed in a pop-up information box, as shown
in Fig. 4. A specific recruitment quantity can be specified
and sites that have less recruitments than specified are
shown by red markers.
Site specific component
Sites may be further analysed by selecting the site on the
map, graph or from a dropdown list. The information of
the selected site, as shown in Fig. 5, consists of the actual
site recruitment information and the simulated remaining
expected duration based on the actual site data. Different
scenarios can be displayed by changing the simulation pa-
rameters to see the effect of changes in recruitment rate
or the number of outstanding recruitments on the pre-
dicted remaining duration.
Fig. 3 Tool multisite planning output
Fig. 4 Site overview map display
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Discussion
The aim of this study was to develop a tool to support
the planning and monitoring of recruitment for clinical
trials. The TRT was developed through close collabor-
ation between clinical trial investigators and industrial
engineers and has the potential to expedite improved
management of clinical trials by providing the appropri-
ate information needed for the planning and monitoring
of the trial recruitment phase.
The TRT has multiple uses including (1) enabling
evidence-based analysis of the feasibility of conducting a
proposed trial within a particular time frame, (2) im-
proved budgeting, resource planning and site selection,
(3) provision of important information that can be used
for engaging stakeholders and (4) supporting the man-
agement and monitoring of the recruitment. These iden-
tified aspects are all components of the Clinical Trials
Transformation Initiative framework recommended by
Huang et al. [4]. Furthermore, the tool is a simple, inter-
active and responsive tool that requires little resources
making it extremely valuable in a resource-constrained
environment, as is common in most LMICs.
TRD prediction methods and models have been a grow-
ing research domain [9, 14–16, 20–23], but minimal work
has been published on how these models may be embed-
ded in the actual trial management context and require
specialised knowledge to use and interpret. This study
demonstrated how a tool can act as a bridge between the-
oretical models and the specific information required by a
trial manager to make management decisions in the trial
context. Alternative and more complex simulation models
as well as analytical approaches for predicting TRD may
be incorporated in the tool. This would however require
potential adaptation of (1) the inputs requested from the
user interface, (2) the backend processing of the user in-
puts and trial data and (3) the model outputs such that it
is compatible with all of the tool components.
This study differs from studies that have developed
dashboards to provide visual summaries of trial informa-
tion. Unlike Toddenroth [31] and Mattingly [32], the
TRT developed in this study simplifies the trial data and
displays only the information required for the actual
management of the trial recruitment process, removing
redundant data. The dashboards developed in these
former studies present descriptive information of his-
toric data whereas the TRT extends this by using the
historic data to present predictive information. This is
particularly valuable for trial managers who can use this
data to be proactive in preventing potential delays in
trial recruitment by taking various informed actions,
such as allocating additional resources to an underper-
forming site.
Several limitations of this study need to be recog-
nised. A simple simulation model was formulated to
predict the TRD since the aim was to develop a usable
and pragmatic solution for demonstration purposes.
The TRD predicted by the simulation model is
dependent on the accuracy of the specified recruitment
rate. During the planning stages, this requires prior
knowledge and does not prevent over- or under-
estimation of the rate. During the recruitment phase,
the recruitment rate is calculated based on the assump-
tion that the rate has been, and will remain, constant
over time. This assumption does however not hold in
certain cases, such as a site being shut down for a
period. The accurate prediction of the recruitment rate
is also found to be problematic in practice, particularly
at the initial stages when no trial data is available. Fur-
thermore, although our suggested simulation approach
appropriately serves the objective of this study, similar
results may be predicted from a simpler analytical ex-
pression derived from the Poisson process since our ap-
proach only considers the basic parameters of the
Poisson distribution.
Fig. 5 Site specific display
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Future research may focus on incorporating more
complex TRD prediction approaches in the tool, such as
that suggested by Minois et al. [22], to mitigate the
former discussed limitations and improve on the as-
sumptions made in this study. The broader study dem-
onstrates the value of collaboration between clinicians
and engineers to optimise their respective skillsets for
the development of practical and impactful solutions to
methodological and trial management challenges. Op-
portunity exists for further intersectoral collaborations
in research and solution development within the clinical
trial environment.
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